MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org on November 12, 2015. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on November 12, 2015. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Fat body mass and pharmacokinetics of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.
Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.
Dermatoglyphics and acute lymphocytic leukemia in children.
Prognosis of black children with acute lymphocytic leukemia.
Availability of varicella vaccine for children with acute lymphocytic leukemia.
Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.
Cranial irradiation and cerebrospinal fluid levels of 6-mercaptopurine in children with acute leukemia.
Granulopoietic studies in acute lymphocytic leukemia of children.
Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia.
The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia.
Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia.
Hypereosinophilia and acute lymphocytic leukemia.
Pattern of 6-mercaptopurine urinary excretion in children with acute lymphoblastic leukemia: urinary assays as a measure of drug compliance.
Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia.
TS Gene Polymorphisms Correlate with Susceptibility to Acute Lymphocytic Leukemia in Children.
Gene rearrangement study for minimal residual disease monitoring in children with acute lymphocytic leukemia.
Therapeutic considerations in acute lymphocytic leukemia.
[Hepatosplenic candidiasis in acute non-lymphocytic leukemia].
Poor prognosis of children with acute lymphocytic leukemia and increased B cell markers.
Cutaneous mucormycosis in a patient with acute lymphocytic leukemia.
Bleomycin-reactive iron in patients with acute non-lymphocytic leukemia.
Campylobacter jejuni Bacteremia in a Patient With Acute Lymphocytic Leukemia.
Risk factors for candidemia in patients with acute lymphocytic leukemia.
Coexistence of Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia.
Pharmacokinetics of mercaptopurine in children with acute lymphocytic leukemia.
The New England Journal of Medicine Downloaded from nejm.org on November 12, 2015. For personal use only. No other uses without permission. Copyright...
409KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Fat body mass and pharmacokinetics of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.
Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.
Dermatoglyphics and acute lymphocytic leukemia in children.
Prognosis of black children with acute lymphocytic leukemia.
Availability of varicella vaccine for children with acute lymphocytic leukemia.
Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.
Cranial irradiation and cerebrospinal fluid levels of 6-mercaptopurine in children with acute leukemia.
Granulopoietic studies in acute lymphocytic leukemia of children.
Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia.
The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms